Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer
Titel:
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer
Auteur:
El-Rayes, Bassel F. Zalupski, Mark M. Manza, Stephanie G. Rusin, Barbara Ferris, Ann Marie Vaishampayan, Ulka Heilbrun, Lance K. Venkatramanamoorthy, Raghu Shields, Anthony F. Philip, Philip A.